Agonist

An agonist is a molecule that binds to a specific receptor and activates it, triggering a downstream biological response. The word sits at the heart of pharmacology: almost every psychoactive substance produces its effects by acting as an agonist at one or more receptor types.

An agonist's potency at a receptor depends on two properties. Affinity describes how tightly it binds; efficacy describes how strongly it activates the receptor once bound. A molecule can bind well but activate weakly — that is a partial agonist. One that binds and activates fully is a full agonist.

How it works · its role

Receptors are proteins, usually embedded in the surface of a cell, shaped to recognise specific molecules. When an agonist docks into a receptor's binding site, it changes the receptor's shape in a way that opens an ion channel, triggers a signalling cascade inside the cell, or both. The cell then does something — fires, releases another chemical, changes gene expression — depending on what that receptor type controls.

The body's own signalling molecules (neurotransmitters, hormones) are natural agonists at their respective receptors. Many psychoactive drugs work by mimicking or amplifying that natural activation, binding to the same site the body's own ligand uses.

Potency also varies by how quickly a drug occupies and releases a receptor — a high-affinity agonist that saturates receptors at low doses can produce strong effects even in small amounts.

Relevance to substances & effects

Agonism underlies the action of most substance classes discussed across the encyclopedia. Opioids — morphine, heroin, oxycodone — are agonists at mu-opioid receptors, which is why they relieve pain and produce euphoria but also slow breathing at high occupancy.

Classic psychedelics such as psilocin and LSD act as partial agonists at the 5-HT₂A serotonin receptor, and most researchers consider that activation central to their perceptual and cognitive effects. Cannabis compounds act as partial agonists at CB₁ and CB₂ cannabinoid receptors, producing the characteristic intoxication and analgesia.

Benzodiazepines are technically positive allosteric modulators rather than direct agonists, but the distinction matters here: they enhance the response to the natural agonist (GABA) rather than replacing it — a subtler form of activation. GABA-A agonists proper, such as barbiturates and alcohol at high doses, bind the receptor more directly and carry a steeper overdose risk as a result.

The difference between a full and partial agonist has practical consequences. Buprenorphine, a partial opioid agonist, activates mu receptors enough to suppress withdrawal but has a ceiling on respiratory depression — a property that makes it useful in treating opioid dependence and gives it a safer profile than full agonists at equivalent occupancy.